Johnson & Johnson has signed a deal with ViiV Healthcare, the HIV-focused venture majority-owned by GlaxoSmithKline, to spin their two antivirals into a single tablet.
written on 12.06.2014
J&J and Glaxo's ViiV venture join up on combo HIV pill
